JPH09502986A - コンホメーションが固定されたヌクレオシド類縁体 - Google Patents
コンホメーションが固定されたヌクレオシド類縁体Info
- Publication number
- JPH09502986A JPH09502986A JP7509961A JP50996195A JPH09502986A JP H09502986 A JPH09502986 A JP H09502986A JP 7509961 A JP7509961 A JP 7509961A JP 50996195 A JP50996195 A JP 50996195A JP H09502986 A JPH09502986 A JP H09502986A
- Authority
- JP
- Japan
- Prior art keywords
- carbocyclic
- group
- cyclopropyl
- compound
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.次の式: [式中、R1はアデニン、グアニン、シトシン、チミン、ウラシル、またはそれ らの誘導体を示し、R2およびR3は独立してHまたはOHを示す] で表される、コンホメーションが固定されたヌクレオシド類縁体。 2.ノーザン(N)型のコンホメーションで固定されている、請求項1に記載 のヌクレオシド類縁体。 3.R2=R3=Hである、請求項1に記載の化合物。 4.R2=OHで、R3=Hである、請求項1に記載の化合物。 5.R2=R3=OHである、請求項1に記載の化合物。 6.炭素環式−4’,6’−シクロプロピル−2’,3’−ジデオキシプリン である、請求項1に記載のヌクレオシド類縁体。 7.炭素環式−4’,6’−シクロプロピル−2’,3’−ジデオキシピリミ ジンである、請求項1に記載のヌクレオシド類縁体。 8.炭素環式−4’,6’−シクロプロピル−2’,3’−ジデオキシアデノ シン。 9.炭素環式−4’,6’−シクロプロピル−2’,3’−ジデオキシグアノ シン。 10.炭素環式−4’,6’−シクロプロピル−2’,3’−ジデオキシウリジ ン。 11.炭素環式−4’,6’−シクロプロピル−2’,3’−ジデオキシシチジ ン。 12.炭素環式−4’,6’−シクロプロピル−2’,3’−ジデオキシチミジ ン。 13.炭素環式−4’,6’−シクロプロピル−2’−デオキシプリンである、 請求項1に記載のヌクレオシド類縁体。 14.炭素環式−4’,6’−シクロプロピル−2’−デオキシピリミジンであ る、請求項1に記載のヌクレオシド類縁体。 15.炭素環式−4’,6’−シクロプロピル−プリン・リボヌクレオシドであ る、請求項1に記載のヌクレオシド類縁体。 16.炭素環式−4’,6’−シクロプロピル−ピリミジン・リボヌクレオシド である、請求項1に記載のヌクレオシド類縁体。 17.炭素環式−4’,6’−シクロプロピル−リボヌクレオシド5’−モノフ ォスフェート。 18.炭素環式−4’,6’−シクロプロピル−リボヌクレオシド5’−モノ− 、ジ−、またはトリ−フォスフェート。 19.請求項4または5に記載の一以上の化合物を含有するオリゴヌクレオチド 。 20.本質的に請求項4または5に記載の化合物から構成されるオリゴヌクレオ チド。 21.コンホメーションが固定されたプリンヌクレオシド類縁体を調製するため のプロセスであって、 (a)シクロプロパン化されたアリルアルコールを含有する炭素環式アルコー ルを提供する段階と、 (b)前記炭素環式アルコールを6−ハロプリンまたは2−アミノ−6−ハロ プリンで縮合させて縮合物[ここにおいて当該プリン誘導体はC1’−N9結合 を介して前記炭素環式アルコールに結合している]を形成する段階と、さらに (c)前記6−ハロプリン縮合物のハロ基をアミノ基で置換してアデノシン類 縁体を得るか、あるいは前記2−アミノ−6−ハロプリンのハロ基を水酸基で置 換してグアノシン類縁体を形成する段階と、を包含するプロセス。 22.前記炭素環式アルコールがジヒドロキシシクロプロパン化アリルアルコー ルであり、前記縮合物がプリンリボヌクレオシド類縁体を含有するものである、 請求項21のプロセス。 23.コンホメーションが固定されたピリミジンヌクレオシド類縁体を調製する ためのプロセスであって、 (a)シクロプロパン化されたアリルアルコールを含有する炭素環式アルコー ルを用意する段階と、 (b)前記炭素環式アルコールをN−3が保護されたチミンまたはN−3が保 護されたウラシルで縮合させて縮合物[ここにおいて当該チミン若しくはウラシ ルの誘導体はC1’−N1結合を介して前記炭素環式アルコールに結合している ]を形成する段階と、 を包含するプロセス。 24.前記炭素環式アルコールが保護されたジヒドロキシシクロプロパン化アリ ルアルコールであり、前記縮合物がピリミジンリボヌクレオシド類縁体を含有す るものである、請求項23に記載のプロセス。 25.コンホメーションが固定されたシチジンヌクレオシド類縁体を調製するた めのプロセスであって、 (a)請求項23に記載のコンホメーションが固定されたウラシルヌクレオシ ド類縁体を調製する段階と、 (b)前記ウラシル類縁体の水酸基を保護する段階と、 (c)前記段階(b)で得られる保護された類縁体を処理してウラシルのC4 においてトリアゾール中間体を形成する段階と、さらに (d)アミノ分解によって前記トリアゾール基を置換させてシチジン類縁体を 得る段階と、 を包含するプロセス。 26.コンホメーションが固定された炭素環式−4’,6’−シクロプロピル− 2’−デオキシピリミジンまたは炭素環式−4’,6’−シクロプロピル−2’ −デオキシプリンを調製する方法であって、 (a)請求項22または24に記載の炭素環式−4,6’−シクロプロピル− プリン・リボヌクレオシドまたは炭素環式−4’,6’−シクロプロピル−ピリ ミジンリボヌクレオシドを調製する段階と、 (b)前記段階(a)で得られる生成物のC−2’ヒドロキシル官能基に対す るラジカル誘導脱酸素によってデオキシヌクレオシド誘導体を形成する段階と、 を包含する方法。 27.次の式: [式中、Rはアルキル基、アリール基、アルキルアリール基、およびアロイル基 からなる群から選択される基を示す]で表される化合物。 28.請求項27に記載の化合物を調製する方法であって、 (a)次の式: [式中、Rはアルキル基、アリール基、アルキルアリール基、およびアロイル基 からなる群から選択される基を示す]で表される化合物を用意する段階と、 (b)段階(a)で得られる化合物をトリメチルアルミニウムと反応させて4 ’位と5’位にそれぞれtert−ブチロキシ置換基およびヒドロキシ置換基を 形成する段階と、 (c)段階(b)で得られる化合物をバルキーな試薬でシリル化して1’位の 水酸基を保護する段階と、 (d)5’位にO−(メチルチオ)チオカルボニロキシ基を形成する段階と、 (e)O−(メチルチオ)チオカルボニロキシ基を除去する段階と、 (f)1’位からシリル基を除去してアリルアルコールを形成する段階と、さ らに (g)前記アリルアルコールをシクロプロパン化して炭素環式アルコールを形 成する段階と、 を包含する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12679693A | 1993-09-24 | 1993-09-24 | |
US08/126,796 | 1993-09-24 | ||
PCT/US1994/010794 WO1995008541A1 (en) | 1993-09-24 | 1994-09-23 | Conformationally locked nucleoside analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09502986A true JPH09502986A (ja) | 1997-03-25 |
JP3481945B2 JP3481945B2 (ja) | 2003-12-22 |
Family
ID=22426712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50996195A Expired - Lifetime JP3481945B2 (ja) | 1993-09-24 | 1994-09-23 | コンホメーションが固定されたヌクレオシド類縁体 |
Country Status (10)
Country | Link |
---|---|
US (2) | US5629454A (ja) |
EP (1) | EP0720604B1 (ja) |
JP (1) | JP3481945B2 (ja) |
AT (1) | ATE160340T1 (ja) |
AU (1) | AU677441B2 (ja) |
DE (1) | DE69406943T2 (ja) |
DK (1) | DK0720604T3 (ja) |
ES (1) | ES2111960T3 (ja) |
GR (1) | GR3026166T3 (ja) |
WO (1) | WO1995008541A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840728A (en) * | 1996-08-07 | 1998-11-24 | United States Of America As Represented By The Department Of Health And Human Services | Conformationally locked nucleoside analogs as antiherpetic agents |
WO1998005662A1 (en) * | 1996-08-07 | 1998-02-12 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Conformationally locked nucleoside analogs as antiherpetic agents |
US7087589B2 (en) | 2000-01-14 | 2006-08-08 | The United States Of America As Represented By The Department Of Health And Human Services | Methanocarba cycloakyl nucleoside analogues |
EP1305296B9 (en) * | 2000-07-26 | 2010-04-07 | The Government of the United States of America, as represented by the Secretary Department of Health and Human Services | 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
US20030032028A1 (en) * | 2001-06-12 | 2003-02-13 | Gayle Dace | In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads |
US20020187479A1 (en) * | 2001-06-12 | 2002-12-12 | Gayle Dace | In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads |
JP4457001B2 (ja) * | 2002-05-31 | 2010-04-28 | セクレタリー・デパートメント・オブ・アトミック・エナジー | ドナー/アクセプター部分が相補鎖上となる標的核酸検出のmet/fretに基づく方法 |
AU2003260292A1 (en) * | 2002-09-11 | 2004-04-30 | Exiqon A/S | A population of nucleic acids including a subpopulation of lna oligomers |
WO2006091905A1 (en) * | 2005-02-25 | 2006-08-31 | Gilead Sciences, Inc. | Bicyclo (3.1.0) hexane derivatives as antiviral compounds |
EP1898935B1 (en) | 2005-05-25 | 2012-09-19 | The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services | North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses |
WO2011068978A1 (en) | 2009-12-02 | 2011-06-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methanocarba adenosine derivatives and dendrimer conjugates thereof |
US10036019B2 (en) | 2014-03-17 | 2018-07-31 | Ionis Pharmaceuticals, Inc. | Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom |
AU2015301248B2 (en) | 2014-08-04 | 2018-10-04 | Auburn University | Enantiomers of the 1',6'-isomer of Neplanocin A |
KR101875997B1 (ko) | 2015-05-04 | 2018-07-06 | 엔 앤드 엔 파마세우티칼스 인크. | 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0577558A2 (de) * | 1992-07-01 | 1994-01-05 | Ciba-Geigy Ag | Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte |
-
1994
- 1994-09-23 AU AU78420/94A patent/AU677441B2/en not_active Expired
- 1994-09-23 ES ES94929321T patent/ES2111960T3/es not_active Expired - Lifetime
- 1994-09-23 WO PCT/US1994/010794 patent/WO1995008541A1/en active IP Right Grant
- 1994-09-23 JP JP50996195A patent/JP3481945B2/ja not_active Expired - Lifetime
- 1994-09-23 AT AT94929321T patent/ATE160340T1/de active
- 1994-09-23 US US08/311,425 patent/US5629454A/en not_active Expired - Lifetime
- 1994-09-23 EP EP94929321A patent/EP0720604B1/en not_active Expired - Lifetime
- 1994-09-23 DK DK94929321T patent/DK0720604T3/da active
- 1994-09-23 DE DE69406943T patent/DE69406943T2/de not_active Expired - Lifetime
-
1997
- 1997-03-14 US US08/818,563 patent/US5869666A/en not_active Expired - Lifetime
-
1998
- 1998-02-18 GR GR980400341T patent/GR3026166T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0720604T3 (da) | 1998-07-27 |
GR3026166T3 (en) | 1998-05-29 |
AU677441B2 (en) | 1997-04-24 |
US5629454A (en) | 1997-05-13 |
EP0720604B1 (en) | 1997-11-19 |
ATE160340T1 (de) | 1997-12-15 |
US5869666A (en) | 1999-02-09 |
ES2111960T3 (es) | 1998-03-16 |
AU7842094A (en) | 1995-04-10 |
EP0720604A1 (en) | 1996-07-10 |
DE69406943D1 (de) | 1998-01-02 |
JP3481945B2 (ja) | 2003-12-22 |
DE69406943T2 (de) | 1998-05-07 |
WO1995008541A1 (en) | 1995-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6525191B1 (en) | Conformationally constrained L-nucleosides | |
WO2003062257A1 (en) | Deazapurine nucleoside analogs and their use as therapeutic agents | |
MXPA00011473A (es) | Nuevos nucleosidos que tienen una porcion de azucar biciclica. | |
Waga et al. | Synthesis and biological evaluation of 4′-C-methyl nucleosides | |
US5200514A (en) | Synthesis of 2'-deoxypyrimidine nucleosides | |
JPH09502986A (ja) | コンホメーションが固定されたヌクレオシド類縁体 | |
US5466793A (en) | Process for preparing 2', 3'- dideoxyinosine | |
Graciet et al. | From D-to L-nucleoside analogs as antiviral agents | |
JPH06501927A (ja) | 2’―フルオロフラノシル誘導体と2’―フルオロピリミジンおよび2’―フルオロプリンヌクレオシドの新しい製造法 | |
Lee et al. | New classes of fluorinated L-nucleosides; synthesis and antiviral activity | |
US5290927A (en) | Process for preparing 2',3'-dideoxyadenosine | |
US5175267A (en) | Stereoselective glycosylation of hetercyclic bases | |
Kotra et al. | Synthesis of 2, 3-dideoxy-2, 2-difluoro-L-glycero-pentofuranosyl nucleosides | |
Jeannot et al. | Synthesis and antiviral evaluation of 2′-deoxy-2′-C-trifluoromethyl β-d-ribonucleoside analogues bearing the five naturally occurring nucleic acid bases | |
WO2021191830A1 (en) | Methods and reagents for synthesizing nucleosides and analogues thereof | |
Zheng et al. | Homologues of Isomeric Dideoxynucleosides as Potential Antiviral Agents: Synthesis of Isodideoxy-Nucleosides with a Furanethanol Sugar Moiety | |
US5144018A (en) | 2',3'-dideoxy-adenosine derivatives | |
CA2172534C (en) | Conformationally locked nucleoside analogues | |
Cooperwood et al. | Synthesis of L-3′-hydroxymethylribonucleosides | |
Richardson et al. | Synthesis and properties of psico-nucleosides | |
US5106962A (en) | Process for preparing 2',3'-dideoxy nucleoside derivatives | |
Li et al. | Synthesis of 2′-C-Branched Nucleosides | |
WO2003052053A2 (en) | Nucleoside libraries and compounds by mcc combinatorial strategies on solid support | |
AU610865B2 (en) | Process to produce 2',3'-dideoxynucleosides | |
WO2000039144A1 (fr) | Procede de preparation de derives fluores de nucleosides et de sucres |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081010 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091010 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091010 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101010 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111010 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121010 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131010 Year of fee payment: 10 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |